Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.

Maslej MM, Furukawa TA, Cipriani A, Andrews PW, Mulsant BH.

JAMA Psychiatry. 2020 Feb 19. doi: 10.1001/jamapsychiatry.2019.4815. [Epub ahead of print]

PMID:
32074273
2.

Fully Defined and Xeno-Free Induction of hPSCs into Neural Crest Using Top-Down Inhibition of BMP Signaling.

Hackland JOS, Frith TJR, Andrews PW.

Methods Mol Biol. 2019;1976:49-54. doi: 10.1007/978-1-4939-9412-0_4.

PMID:
30977064
3.

Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform.

Stacey GN, Andrews PW, Barbaric I, Boiers C, Chandra A, Cossu G, Csontos L, Frith TJ, Halliwell JA, Hewitt Z, McCall M, Moore HD, Parmar M, Panico MB, Pisupati V, Shichkin VP, Stacey AR, Tedesco FS, Thompson O, Wagey R.

Regen Med. 2019 Mar;14(3):243-255. doi: 10.2217/rme-2019-0001. Epub 2019 Apr 2.

4.

Recent Developments in the Treatment of Depression.

Hollon SD, Cohen ZD, Singla DR, Andrews PW.

Behav Ther. 2019 Mar;50(2):257-269. doi: 10.1016/j.beth.2019.01.002. Epub 2019 Jan 17. Review.

PMID:
30824244
5.

Anti-apoptotic Mutations Desensitize Human Pluripotent Stem Cells to Mitotic Stress and Enable Aneuploid Cell Survival.

Zhang J, Hirst AJ, Duan F, Qiu H, Huang R, Ji Y, Bai L, Zhang F, Robinson D, Jones M, Li L, Wang P, Jiang P, Andrews PW, Barbaric I, Na J.

Stem Cell Reports. 2019 Mar 5;12(3):557-571. doi: 10.1016/j.stemcr.2019.01.013. Epub 2019 Feb 14.

6.

Human axial progenitors generate trunk neural crest cells in vitro.

Frith TJ, Granata I, Wind M, Stout E, Thompson O, Neumann K, Stavish D, Heath PR, Ortmann D, Hackland JO, Anastassiadis K, Gouti M, Briscoe J, Wilson V, Johnson SL, Placzek M, Guarracino MR, Andrews PW, Tsakiridis A.

Elife. 2018 Aug 10;7. pii: e35786. doi: 10.7554/eLife.35786.

7.

Identification and Single-Cell Functional Characterization of an Endodermally Biased Pluripotent Substate in Human Embryonic Stem Cells.

Allison TF, Smith AJH, Anastassiadis K, Sloane-Stanley J, Biga V, Stavish D, Hackland J, Sabri S, Langerman J, Jones M, Plath K, Coca D, Barbaric I, Gokhale P, Andrews PW.

Stem Cell Reports. 2018 Jun 5;10(6):1895-1907. doi: 10.1016/j.stemcr.2018.04.015. Epub 2018 May 17.

8.

Reply.

Maslej MM, Bolker BM, Hollon SD, Mulsant BH, Andrews PW.

Psychother Psychosom. 2018;87(3):180. doi: 10.1159/000488113. Epub 2018 Apr 4. No abstract available.

PMID:
29617691
9.

Acquired Genetic and Epigenetic Variation in Human Pluripotent Stem Cells.

Kyriakides O, Halliwell JA, Andrews PW.

Adv Biochem Eng Biotechnol. 2018;163:187-206. doi: 10.1007/10_2017_22. Review.

10.

Top-Down Inhibition of BMP Signaling Enables Robust Induction of hPSCs Into Neural Crest in Fully Defined, Xeno-free Conditions.

Hackland JOS, Frith TJR, Thompson O, Marin Navarro A, Garcia-Castro MI, Unger C, Andrews PW.

Stem Cell Reports. 2017 Oct 10;9(4):1043-1052. doi: 10.1016/j.stemcr.2017.08.008. Epub 2017 Sep 14.

11.

The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis.

Maslej MM, Bolker BM, Russell MJ, Eaton K, Durisko Z, Hollon SD, Swanson GM, Thomson JA Jr, Mulsant BH, Andrews PW.

Psychother Psychosom. 2017;86(5):268-282. doi: 10.1159/000477940. Epub 2017 Sep 14. Review.

PMID:
28903117
12.

Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications.

Andrews PW, Ben-David U, Benvenisty N, Coffey P, Eggan K, Knowles BB, Nagy A, Pera M, Reubinoff B, Rugg-Gunn PJ, Stacey GN.

Stem Cell Reports. 2017 Jul 11;9(1):1-4. doi: 10.1016/j.stemcr.2017.05.029.

13.

Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.

Damjanov I, Andrews PW.

Int J Dev Biol. 2016;60(10-11-12):337-419. doi: 10.1387/ijdb.160274id.

14.

Pluripotent human stem cells: Standing on the shoulders of giants.

Damjanov I, Andrews PW.

Int J Dev Biol. 2016;60(10-11-12):321-325. doi: 10.1387/ijdb.160437id.

15.

Reverse Engineering the Febrile System.

Shepard AM, Bharwani A, Durisko Z, Andrews PW.

Q Rev Biol. 2016 Dec;91(4):419-57. Review.

PMID:
29562118
16.

Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells.

Baker D, Hirst AJ, Gokhale PJ, Juarez MA, Williams S, Wheeler M, Bean K, Allison TF, Moore HD, Andrews PW, Barbaric I.

Stem Cell Reports. 2016 Nov 8;7(5):998-1012. doi: 10.1016/j.stemcr.2016.10.003.

17.

Current Biosafety Considerations in Stem Cell Therapy.

Mousavinejad M, Andrews PW, Shoraki EK.

Cell J. 2016 Jul-Sep;18(2):281-7. Epub 2016 May 30.

18.

The source dilemma hypothesis: Perceptual uncertainty contributes to musical emotion.

Bonin TL, Trainor LJ, Belyk M, Andrews PW.

Cognition. 2016 Sep;154:174-181. doi: 10.1016/j.cognition.2016.05.021. Epub 2016 Jun 16.

PMID:
27318599
19.

Using Evolutionary Theory to Guide Mental Health Research.

Durisko Z, Mulsant BH, McKenzie K, Andrews PW.

Can J Psychiatry. 2016 Mar;61(3):159-65. doi: 10.1177/0706743716632517. Epub 2016 Feb 12. Review.

20.

White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies.

Burns AJ, Goldstein AM, Newgreen DF, Stamp L, Schäfer KH, Metzger M, Hotta R, Young HM, Andrews PW, Thapar N, Belkind-Gerson J, Bondurand N, Bornstein JC, Chan WY, Cheah K, Gershon MD, Heuckeroth RO, Hofstra RM, Just L, Kapur RP, King SK, McCann CJ, Nagy N, Ngan E, Obermayr F, Pachnis V, Pasricha PJ, Sham MH, Tam P, Vanden Berghe P.

Dev Biol. 2016 Sep 15;417(2):229-51. doi: 10.1016/j.ydbio.2016.04.001. Epub 2016 Apr 5. Review.

21.

The origins of stem cells as tools for regenerative medicine.

Andrews PW, Elvasorre N.

Biochem Biophys Res Commun. 2016 May 6;473(3):663-4. doi: 10.1016/j.bbrc.2016.03.032. Epub 2016 Mar 10. No abstract available.

PMID:
26970309
22.

Identification of Novel Fusion Genes in Testicular Germ Cell Tumors.

Hoff AM, Alagaratnam S, Zhao S, Bruun J, Andrews PW, Lothe RA, Skotheim RI.

Cancer Res. 2016 Jan 1;76(1):108-16. doi: 10.1158/0008-5472.CAN-15-1790. Epub 2015 Dec 9.

23.

Evidence for bystander signalling between human trophoblast cells and human embryonic stem cells.

Jones AJ, Gokhale PJ, Allison TF, Sampson B, Athwal S, Grant S, Andrews PW, Allen ND, Case CP.

Sci Rep. 2015 Jul 14;5:11694. doi: 10.1038/srep11694.

24.

Culture adaptation alters transcriptional hierarchies among single human embryonic stem cells reflecting altered patterns of differentiation.

Gokhale PJ, Au-Young JK, Dadi S, Keys DN, Harrison NJ, Jones M, Soneji S, Enver T, Sherlock JK, Andrews PW.

PLoS One. 2015 Apr 14;10(4):e0123467. doi: 10.1371/journal.pone.0123467. eCollection 2015.

25.

Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies.

Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J, Baty R, Graziano EI, Proto Marco B, Caron A, Sköld P, Andrews PW, Baxter MA, Hay DC, Hamdam J, Sharpe ME, Patel S, Jones DR, Reinhardt J, Danen EH, Ben-David U, Stacey G, Björquist P, Piner J, Mills J, Rowe C, Pellegrini G, Sethu S, Antoine DJ, Cross MJ, Murray P, Williams DP, Kitteringham NR, Goldring CE, Park BK.

Stem Cells Transl Med. 2015 Apr;4(4):389-400. doi: 10.5966/sctm.2014-0110. Epub 2015 Feb 26. Review.

26.

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).

Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brüstle O, Choi M, Choi YM, Crook JM, de Sousa PA, Dvorak P, Freund C, Firpo M, Furue MK, Gokhale P, Ha HY, Han E, Haupt S, Healy L, Hei DJ, Hovatta O, Hunt C, Hwang SM, Inamdar MS, Isasi RM, Jaconi M, Jekerle V, Kamthorn P, Kibbey MC, Knezevic I, Knowles BB, Koo SK, Laabi Y, Leopoldo L, Liu P, Lomax GP, Loring JF, Ludwig TE, Montgomery K, Mummery C, Nagy A, Nakamura Y, Nakatsuji N, Oh S, Oh SK, Otonkoski T, Pera M, Peschanski M, Pranke P, Rajala KM, Rao M, Ruttachuk R, Reubinoff B, Ricco L, Rooke H, Sipp D, Stacey GN, Suemori H, Takahashi TA, Takada K, Talib S, Tannenbaum S, Yuan BZ, Zeng F, Zhou Q.

Regen Med. 2015;10(2 Suppl):1-44. doi: 10.2217/rme.14.93. No abstract available.

PMID:
25675265
27.

Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response.

Andrews PW, Bharwani A, Lee KR, Fox M, Thomson JA Jr.

Neurosci Biobehav Rev. 2015 Apr;51:164-88. doi: 10.1016/j.neubiorev.2015.01.018. Epub 2015 Jan 24. Review.

PMID:
25625874
28.

An adaptationist perspective on the etiology of depression.

Durisko Z, Mulsant BH, Andrews PW.

J Affect Disord. 2015 Feb 1;172:315-23. doi: 10.1016/j.jad.2014.09.032. Epub 2014 Sep 28. Review.

PMID:
25451432
29.

Measuring the bright side of being blue: a new tool for assessing analytical rumination in depression.

Barbic SP, Durisko Z, Andrews PW.

PLoS One. 2014 Nov 14;9(11):e112077. doi: 10.1371/journal.pone.0112077. eCollection 2014.

30.

Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells.

Ben-David U, Arad G, Weissbein U, Mandefro B, Maimon A, Golan-Lev T, Narwani K, Clark AT, Andrews PW, Benvenisty N, Carlos Biancotti J.

Nat Commun. 2014 Sep 8;5:4825. doi: 10.1038/ncomms5825.

PMID:
25198699
31.

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells.

Andrews PW, Cavagnaro J, Deans R, Feigal E, Horowitz E, Keating A, Rao M, Turner M, Wilmut I, Yamanaka S.

Nat Biotechnol. 2014 Aug;32(8):724-6. doi: 10.1038/nbt.2973. No abstract available. Erratum in: Nat Biotechnol. 2014 Nov;32(11):1166. Cavanagro, Joy [corrected to Cavagnaro, Joy]; Feigel, Ellen [corrected to Feigal, Ellen].

PMID:
25093882
32.

Induced pluripotency enables differentiation of human nullipotent embryonal carcinoma cells N2102Ep.

Sutiwisesak R, Kitiyanant N, Kotchabhakdi N, Felsenfeld G, Andrews PW, Wongtrakoongate P.

Biochim Biophys Acta. 2014 Nov;1843(11):2611-9. doi: 10.1016/j.bbamcr.2014.07.013. Epub 2014 Jul 30.

33.

Time-lapse analysis of human embryonic stem cells reveals multiple bottlenecks restricting colony formation and their relief upon culture adaptation.

Barbaric I, Biga V, Gokhale PJ, Jones M, Stavish D, Glen A, Coca D, Andrews PW.

Stem Cell Reports. 2014 Jun 12;3(1):142-55. doi: 10.1016/j.stemcr.2014.05.006. eCollection 2014 Jul 8.

34.

Aneuploidy in pluripotent stem cells and implications for cancerous transformation.

Na J, Baker D, Zhang J, Andrews PW, Barbaric I.

Protein Cell. 2014;5(8):569-79. doi: 10.1007/s13238-014-0073-9. Epub 2014 Jun 5. Review.

35.

Identifiability and privacy in pluripotent stem cell research.

Isasi R, Andrews PW, Baltz JM, Bredenoord AL, Burton P, Chiu IM, Hull SC, Jung JW, Kurtz A, Lomax G, Ludwig T, McDonald M, Morris C, Ng HH, Rooke H, Sharma A, Stacey GN, Williams C, Zeng F, Knoppers BM.

Cell Stem Cell. 2014 Apr 3;14(4):427-30. doi: 10.1016/j.stem.2014.03.014.

36.

Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives.

Wongtrakoongate P, Li J, Andrews PW.

Br J Cancer. 2014 Apr 15;110(8):2131-8. doi: 10.1038/bjc.2014.128. Epub 2014 Mar 6.

37.

Hygiene and the world distribution of Alzheimer's disease: Epidemiological evidence for a relationship between microbial environment and age-adjusted disease burden.

Fox M, Knapp LA, Andrews PW, Fincher CL.

Evol Med Public Health. 2013 Jan;2013(1):173-86. doi: 10.1093/emph/eot015. Epub 2013 Aug 11.

38.

Population-level effects of suppressing fever.

Earn DJ, Andrews PW, Bolker BM.

Proc Biol Sci. 2014 Jan 22;281(1778):20132570. doi: 10.1098/rspb.2013.2570. Print 2014 Mar 7.

39.

DNMT3B inhibits the re-expression of genes associated with induced pluripotency.

Wongtrakoongate P, Li J, Andrews PW.

Exp Cell Res. 2014 Feb 15;321(2):231-9. doi: 10.1016/j.yexcr.2013.11.024. Epub 2013 Dec 10.

PMID:
24333507
40.

BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures.

Avery S, Hirst AJ, Baker D, Lim CY, Alagaratnam S, Skotheim RI, Lothe RA, Pera MF, Colman A, Robson P, Andrews PW, Knowles BB.

Stem Cell Reports. 2013 Oct 31;1(5):379-86. doi: 10.1016/j.stemcr.2013.10.005. eCollection 2013.

41.

Characterization of human pluripotent stem cells.

Gokhale PJ, Andrews PW.

Neuroreport. 2013 Dec 18;24(18):1031-4. doi: 10.1097/WNR.0000000000000040.

PMID:
24089015
42.

ESTOOLS Data@Hand: human stem cell gene expression resource.

Kong L, Aho KL, Granberg K, Lund R, Järvenpää L, Seppälä J, Gokhale P, Leinonen K, Hahne L, Mäkelä J, Laurila K, Pukkila H, Närvä E, Yli-Harja O, Andrews PW, Nykter M, Lahesmaa R, Roos C, Autio R.

Nat Methods. 2013 Sep;10(9):814-5. doi: 10.1038/nmeth.2576. No abstract available.

PMID:
23985726
43.

Karyotypically abnormal human ESCs are sensitive to HDAC inhibitors and show altered regulation of genes linked to cancers and neurological diseases.

Lund RJ, Emani MR, Barbaric I, Kivinen V, Jones M, Baker D, Gokhale P, Nykter M, Lahesmaa R, Andrews PW.

Stem Cell Res. 2013 Nov;11(3):1022-36. doi: 10.1016/j.scr.2013.07.002. Epub 2013 Jul 18.

44.

STELLA facilitates differentiation of germ cell and endodermal lineages of human embryonic stem cells.

Wongtrakoongate P, Jones M, Gokhale PJ, Andrews PW.

PLoS One. 2013;8(2):e56893. doi: 10.1371/journal.pone.0056893. Epub 2013 Feb 14.

45.

Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cells.

Alagaratnam S, Harrison N, Bakken AC, Hoff AM, Jones M, Sveen A, Moore HD, Andrews PW, Lothe RA, Skotheim RI.

Stem Cells Dev. 2013 Apr 1;22(7):1136-46. doi: 10.1089/scd.2012.0369. Epub 2013 Jan 4.

PMID:
23137282
46.

Restoration of auditory evoked responses by human ES-cell-derived otic progenitors.

Chen W, Jongkamonwiwat N, Abbas L, Eshtan SJ, Johnson SL, Kuhn S, Milo M, Thurlow JK, Andrews PW, Marcotti W, Moore HD, Rivolta MN.

Nature. 2012 Oct 11;490(7419):278-82. doi: 10.1038/nature11415. Epub 2012 Sep 12.

47.

The development of pluripotent stem cells.

Gokhale PJ, Andrews PW.

Curr Opin Genet Dev. 2012 Oct;22(5):403-8. doi: 10.1016/j.gde.2012.07.006. Epub 2012 Aug 3. Review.

PMID:
22868175
48.

Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells.

Hyka-Nouspikel N, Desmarais J, Gokhale PJ, Jones M, Meuth M, Andrews PW, Nouspikel T.

Stem Cells. 2012 Sep;30(9):1901-10. doi: 10.1002/stem.1177.

49.

Disclosure and management of research findings in stem cell research and banking: policy statement.

Isasi R, Knoppers BM, Andrews PW, Bredenoord A, Colman A, Hin LE, Hull S, Kim OJ, Lomax G, Morris C, Sipp D, Stacey G, Wahlstrom J, Zeng F; International Stem Cell Forum Ethics Working Party.

Regen Med. 2012 May;7(3):439-48. doi: 10.2217/rme.12.23.

PMID:
22594334
50.

Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress.

Desmarais JA, Hoffmann MJ, Bingham G, Gagou ME, Meuth M, Andrews PW.

Stem Cells. 2012 Jul;30(7):1385-93. doi: 10.1002/stem.1117.

Supplemental Content

Loading ...
Support Center